Update license

LICENSE.md

@@ -10,13 +10,13 @@ Alchemab Therapeutics is making AntiBERTa2, specifically its parameter weights,
 | ----------- | ----------  | ---------- |
 | Private use | No commercial use | Attaching this license |
 | Research and academic use | No use for pre-clinical or clinical tests or studies | Notices |
-| Creating antibody variants | No developing, generating, or synthesising reagent, diagnostic or therapeutic antibodies for *in vitro* or *in vivo* studies | Attribution | 
+| Generating and synthesising antibodies | No developing, generating, or synthesising reagent, diagnostic or therapeutic antibodies for *in vitro* or *in vivo* studies | Attribution | 
 | Reproduction | "as is" warranties | |
 | Modification | No liability | |
 | Distribution | | 
 
 
-## TERMS AND CONDITIONS FOR USE, REPRODUCTIONAND DISTRIBUTION OF FABCON
+## TERMS AND CONDITIONS FOR USE, REPRODUCTIONAND DISTRIBUTION OF ANTIBERTA2
 1. Definitions.
 "License" shall mean these terms and conditions for use, reproduction, and distribution of the Work as defined by Sections 1 through 9 of this document.
 "Licensor" shall mean Alchemab Therapeutics Ltd, the copyright owner or entity authorized by the copyright owner that is granting the License.
@@ -35,7 +35,7 @@ Alchemab Therapeutics is making AntiBERTa2, specifically its parameter weights,
 3. Grant of Patent License. Subject to the terms and conditions of this License, each Contributor hereby grants to You a perpetual, worldwide, non-exclusive, no-charge, royalty-free, irrevocable (except as stated in this section) patent license to use and transfer the Work, and for other uses, including (but not limited to) generating antibodies, provided always that such rights are for non-commercial research and academic purposes only, where such license applies only to those patent claims licensable by such Contributor that are necessarily infringed by their Contribution(s) alone or by combination of their Contribution(s) with the Work to which such Contribution(s) was submitted. If You institute patent litigation against any entity (including a cross-claim or counterclaim in a lawsuit) alleging that the Work or a Contribution incorporated within the Work constitutes direct or contributory patent infringement, then any patent licenses granted to You under this License for that Work shall terminate as of the date such litigation is filed.
 
 4. License Exclusions. This License, specifically as described in sections 2 and 3, does NOT extend to any commercial use, pre-clinical or clinical tests or studies, or use for the purpose of developing, generating or synthesising reagent, diagnostic or therapeutic antibodies for in vitro or in vivo studies or trials, in relation to the Work or any generated antibodies, whether currently intended, contemplated or foreseeable or not.
-If You want to extend the License to cover any of the aforementioned exclusions, please contact the Licensor at this email address: [INSERT].
+If You want to extend the License to cover any of the aforementioned exclusions, please contact the Licensor at this email address: [info@alchemab.com](mailto:info@alchemab.com).
 
 5. Redistribution. You may reproduce and distribute copies of the Work or Derivative Works thereof in any medium, without modifications, and in Source or Object form, provided that You meet the following conditions:
 * You must give any other recipients of the Work or Derivative Works a copy of this License, which will apply to the use of the Work or such Derivative Works including (without limitation) the limitations and exclusions to the License; and